{
    "startDate": "2022-01-01",
    "endDate": "2022-03-31",
    "year": "2022",
    "quarter": "Q1",
    "symbol": "RANI",
    "data": {
        "bs": [
            {
                "label": "Preferred stock, $0.0001 par value - 20,000 shares authorized; none issued and outstanding as of March 31, 2022",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 115309000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 107839000
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 1159000
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 1159000
            },
            {
                "label": "Total stockholders' equity attributable to Rani Therapeutics Holdings, Inc.",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 53384000
            },
            {
                "label": "Commitments and contingencies (Note 10)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Operating lease liability, net current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 509000
            },
            {
                "label": "Operating lease liability, net current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 509000
            },
            {
                "label": "Operating lease liability, net current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 509000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -14554000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -14600000.0
            },
            {
                "label": "Additional Paid in Capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 67933000
            },
            {
                "label": "Total liabilities and stockholders' equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 115309000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1265000
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 4665000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 4890000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 110644000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 110644000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2101000
            },
            {
                "label": "Prepaid expenses",
                "concept": "PrepaidExpenseCurrent",
                "unit": "usd",
                "value": 1421000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 4156000
            },
            {
                "label": "Non-controlling interest",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 57260000
            },
            {
                "label": "Related party payable",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 140000
            },
            {
                "label": "Operating lease liability, current portion",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 650000
            },
            {
                "label": "Operating lease liability, current portion",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 650000
            },
            {
                "label": "Operating lease liability, current portion",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 650000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 109260000
            }
        ],
        "cf": [
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -254000
            },
            {
                "label": "Equity-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 2905000
            },
            {
                "label": "Proceeds from exercise of warrants for common units",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -9360000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -9400000.0
            },
            {
                "label": "Operating lease liabilities",
                "concept": "IncreaseDecreaseInOperatingLeaseLiability",
                "unit": "usd",
                "value": -157000
            },
            {
                "label": "Other",
                "concept": "OtherOperatingActivitiesCashFlowStatement",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -13828000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -13828000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -13828000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -13800000.0
            },
            {
                "label": "Related party payable",
                "concept": "IncreaseDecreaseInAccountsPayableRelatedParties",
                "unit": "usd",
                "value": 14000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -721000
            },
            {
                "label": "Principal and interest repayments from related party for note receivable",
                "concept": "ProceedsFromRelatedPartyDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 639000
            },
            {
                "label": "Property and equipment purchases included in accounts payable and accrued expenses",
                "concept": "CapitalExpendituresIncurredButNotYetPaid",
                "unit": "usd",
                "value": 135000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 254000
            },
            {
                "label": "Proceeds from issuance of preferred units, net of issuance costs",
                "concept": "ProceedsFromIssuanceOfPreferredLimitedPartnersUnits",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net (decrease) increase in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -9614000
            },
            {
                "label": "Payment of deferred offering costs",
                "concept": "rani:PaymentOfDeferredOfferingCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of preferred unit warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of preferred unit warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Deferred Financing Costs Included In Accrued Expenses",
                "concept": "rani:DeferredFinancingCostsIncludedInAccruedExpenses",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayableTrade",
                "unit": "usd",
                "value": 78000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Depreciation and amortization",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 111000
            },
            {
                "label": "Non-cash operating lease expense",
                "concept": "OperatingLeaseRightOfUseAssetAmortizationExpense",
                "unit": "usd",
                "value": 157000
            }
        ],
        "ic": [
            {
                "label": "Income tax expense",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 63000
            },
            {
                "label": "Loss before income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -13765000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 6189000
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 13780000
            },
            {
                "label": "Net loss and comprehensive loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -13828000
            },
            {
                "label": "Net loss and comprehensive loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -13828000
            },
            {
                "label": "Net loss and comprehensive loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -13828000
            },
            {
                "label": "Net loss and comprehensive loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -13800000.0
            },
            {
                "label": "Contract revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net loss attributable to non-controlling interest",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -7605000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -13780000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 7591000
            },
            {
                "label": "Change in estimated fair value of preferred unit warrant",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in estimated fair value of preferred unit warrant",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc., basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.29
            },
            {
                "label": "Net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc., basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.29
            },
            {
                "label": "Weighted-average Class A common shares outstanding-basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 21409000
            },
            {
                "label": "Weighted-average Class A common shares outstanding-basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 21409000
            },
            {
                "label": "Interest expense and other, net",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 15000
            },
            {
                "label": "Net loss attributable to Rani Therapeutics Holdings, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -6223000
            },
            {
                "label": "Net loss attributable to Rani Therapeutics Holdings, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -6223000
            }
        ]
    }
}